...
机译:校长治疗HPV阳性头和颈部癌症中MTOR表达的预后意义
Department of Radiation OncologyWilliam Beaumont HospitalRoyal Oak Michigan;
Department of Radiation OncologyWilliam Beaumont HospitalRoyal Oak Michigan;
Oakland University William Beaumont School of MedicineOakland UniversityRochester Michigan;
Beaumont BioBankWilliam Beaumont HospitalRoyal Oak Michigan;
Department of Human Oncology University of Wisconsin Carbone Cancer Center School of Medicine and;
Department of Radiation OncologyWilliam Beaumont HospitalRoyal Oak Michigan;
chemoradiation; head and neck cancer; HPV; image analysis; MTOR;
机译:校长治疗HPV阳性头和颈部癌症中MTOR表达的预后意义
机译:I阶段研究AFATINIB / CARBOPOLTATIN / PACLITAXEL诱导化疗,然后用HPV阴性或高风险HPV阳性局部晚期III / IVA / IVB头颈和颈鳞状细胞癌的标准校准
机译:肿瘤浸润淋巴细胞,PD-L1表达和HPV / P16与生物或颈部癌中HPV / P16相关性的临床相关性
机译:HPV阳性和负浸润宫颈腺癌中PL6〜(INK4A)的过表达
机译:2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床,组织病理学和生物学参数的预后意义
机译:I期研究afatinib / carboplatin / paclitaxel诱导化疗然后在HPV阴性或高危HPV阳性局部晚期III / IVa / IVb头颈部鳞状细胞癌中进行标准化学放疗
机译:内在放射敏感性不是HPV阴性和HPV阳性头和颈癌之间治疗反应差异的决定因素